259 FEATURES PREDICTING WORSE POSTOPERATIVE HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ESOPHAGEAL CANCER: RESULTS FROM THE CROSS-TRIAL
Bernadetta Wilk(Erasmus MC), J. J. van Lanschot(Erasmus MC), Jan J.V. Busschbach(Erasmus University Rotterdam), Sjoerd M. Lagarde(University of Amsterdam), R. Timman(Erasmus MC), Ben M. Eyck(Erasmus MC Cancer Institute), Bas P. L. Wijnhoven(Inserm), Leonieke W. Kranenburg(Erasmus MC)
Cited by 0
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
|Annals of Surgery|2007|709
The Indonesian EQ-5D-5L Value Set
|PharmacoEconomics|2017|202